Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Apple
AAPL
|
+$975M |
| 2 |
Amazon
AMZN
|
+$708M |
| 3 |
UnitedHealth
UNH
|
+$634M |
| 4 |
Rivian
RIVN
|
+$504M |
| 5 |
TJX Companies
TJX
|
+$483M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$1.1B |
| 2 |
NVIDIA
NVDA
|
+$814M |
| 3 |
L3Harris
LHX
|
+$714M |
| 4 |
Zurn Elkay Water Solutions
ZWS
|
+$503M |
| 5 |
Texas Instruments
TXN
|
+$468M |
Sector Composition
| 1 | Technology | 32.52% |
| 2 | Healthcare | 18.41% |
| 3 | Consumer Discretionary | 11.42% |
| 4 | Financials | 9.67% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
776
Schlumberger
SLB
$54.2B
| $20.7M | 0.01% |
691,028
-899
| -0.1% | -$26.9K |
|
777
AT&T
T
$210B
| $20.7M | 0.01% |
1,112,806
-125,698
| -10% | -$2.34M |
|
|
CYT
778
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
| $20.6M | 0.01% |
1,872,421
-5,803
| -0.3% | -$63.9K |
|
|
HSKA
779
DELISTED
Heska Corp
HSKA
| $20.5M | 0.01% |
112,545
-30,660
| -21% | -$5.6M |
|
780
Anika Therapeutics
ANIK
$124M
| $20.5M | 0.01% |
571,895
+108,110
| +23% | +$3.87M |
|
781
EyePoint Pharmaceuticals
EYPT
$928M
| $20.5M | 0.01% |
1,671,183
+958,799
| +135% | +$11.7M |
|
782
Franklin FTSE Japan ETF
FLJP
$2.4B
| $20.4M | 0.01% |
694,833
+16,097
| +2% | +$473K |
|
783
Darden Restaurants
DRI
$24.7B
| $20.4M | 0.01% |
135,104
-495,597
| -79% | -$74.7M |
|
784
Perimeter Solutions
PRM
$3.28B
| $20.3M | 0.01% |
+1,461,014
| New | +$20.3M |
|
785
PNC Financial Services
PNC
$79.8B
| $20.2M | 0.01% |
100,662
-168,278
| -63% | -$33.7M |
|
|
NLSN
786
DELISTED
Nielsen Holdings plc
NLSN
| $20.2M | 0.01% |
983,486
+929,387
| +1,718% | +$19.1M |
|
787
GitLab
GTLB
$8.32B
| $20.1M | 0.01% |
+230,933
| New | +$20.1M |
|
788
CarParts.com
PRTS
$46.3M
| $20.1M | 0.01% |
1,792,741
+701,042
| +64% | +$7.85M |
|
789
Fortune Brands Innovations
FBIN
$7.24B
| $20M | 0.01% |
218,349
+173,319
| +385% | +$15.8M |
|
790
Northern Trust
NTRS
$24.6B
| $19.9M | 0.01% |
166,038
-87,858
| -35% | -$10.5M |
|
|
WBA
791
DELISTED
Walgreens Boots Alliance
WBA
| $19.8M | 0.01% |
380,263
-376,656
| -50% | -$19.6M |
|
792
Mirion Technologies
MIR
$5.14B
| $19.8M | 0.01% |
1,892,034
+822,472
| +77% | +$8.61M |
|
793
ALX Oncology
ALXO
$65.9M
| $19.8M | 0.01% |
918,908
-106,491
| -10% | -$2.29M |
|
794
C.H. Robinson
CHRW
$15.4B
| $19.4M | 0.01% |
180,104
-101,138
| -36% | -$10.9M |
|
795
Montrose Environmental
MEG
$1.07B
| $19.3M | 0.01% |
273,811
-93,355
| -25% | -$6.58M |
|
|
UMH
796
UMH Properties
UMH
$1.29B
| $19.3M | 0.01% |
+705,531
| New | +$19.3M |
|
|
ABMD
797
DELISTED
Abiomed Inc
ABMD
| $19.1M | 0.01% |
53,095
-28,232
| -35% | -$10.1M |
|
798
Design Therapeutics
DSGN
$345M
| $19.1M | 0.01% |
936,767
+108
| +0% | +$2.2K |
|
799
ScottsMiracle-Gro
SMG
$3.54B
| $19M | 0.01% |
117,769
-13,963
| -11% | -$2.25M |
|
800
3M
MMM
$83.9B
| $18.9M | 0.01% |
127,195
-138,571
| -52% | -$20.6M |
|